Literature DB >> 12121224

Possible mechanism for the alpha subunit of the interleukin-2 receptor (CD25) to influence interleukin-2 receptor signal transduction.

Jonathan M Ellery1, Peter J Nicholls.   

Abstract

The receptors for interleukin 2 (IL-2) and interleukin 15 (IL-15) in T cells share the IL-2R beta subunit (CD122) and gamma(C) subunit but have private alpha subunits. Despite utilizing the same receptor chains known to be necessary and sufficient to transduce IL-2 signals the two cytokines manifest different cellular effects. It is commonly held that the alpha subunit of the IL-2R (CD25) is involved solely in the generation of a high affinity receptor complex. This is questioned by the development of autoimmune diseases in instances where the expression of CD25 is absent. The timely expression of CD25 in the thymus has been linked with clonal deletion. Evidence from peripheral T cells indicates that survival signals arising from the intermediate affinity IL-2R (lacking CD25) do not require the activation of Janus kinase 3 (Jak3) but do require the presence of the membrane proximal region of the gamma(C) chain. This particular signalling pathway is not observed in the high affinity receptor complex where Jak3 is activated. Recent data point to CD25 having a surface distribution consistent with it being localized within membrane microdomains. Here we suggest that in the absence of CD25 expression, IL-2R activation occurs within the soluble membrane fraction. This membrane environment and the absence of CD25 promotes Jak3 independent signal transduction and induction of antiapoptotic mechanisms. T cell antigen receptor (TCR) signalling leads to the induction of CD25 expression, which localizes to membrane microdomains. There is a dynamic pre-association of CD25 and CD122 leading to the loose association of the heterodimer with membrane microdomains. High affinity IL-2R signalling in the context of CD25 and the microdomain environment is characterized by Jak3 activation. The relative levels of high to intermediate affinity receptor signalling determines whether a cell proliferates or undergoes activation induced cell death dependent upon cell status.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12121224     DOI: 10.1046/j.1440-1711.2002.01097.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  12 in total

1.  Impaired up-regulation of CD25 on CD4+ T cells in IFN-gamma knockout mice is associated with progression of myocarditis to heart failure.

Authors:  Marina Afanasyeva; Dimitrios Georgakopoulos; Diego F Belardi; Djahida Bedja; Delisa Fairweather; Yan Wang; Ziya Kaya; Kathleen L Gabrielson; E Rene Rodriguez; Patrizio Caturegli; David A Kass; Noel R Rose
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-20       Impact factor: 11.205

2.  Oncostatin M Suppresses Activation of IL-17/Th17 via SOCS3 Regulation in CD4+ T Cells.

Authors:  Hye-Jin Son; Seung Hoon Lee; Seon-Yeong Lee; Eun-Kyung Kim; Eun-Ji Yang; Jae-Kyung Kim; Hyeon-Beom Seo; Sung-Hwan Park; Mi-La Cho
Journal:  J Immunol       Date:  2017-01-16       Impact factor: 5.422

3.  The effects of interleukin-2 on immune response regulation.

Authors:  Ryan S Waters; Justin S A Perry; SunPil Han; Bibiana Bielekova; Tomas Gedeon
Journal:  Math Med Biol       Date:  2018-03-14       Impact factor: 1.854

4.  The common gamma chain cytokines interleukin (IL)-2 and IL-7 indirectly modulate blood fluke development via effects on CD4+ T cells.

Authors:  Rebecca B Blank; Erika W Lamb; Anna S Tocheva; Emily T Crow; K C Lim; James H McKerrow; Stephen J Davies
Journal:  J Infect Dis       Date:  2006-10-23       Impact factor: 5.226

5.  Blood fluke exploitation of non-cognate CD4+ T cell help to facilitate parasite development.

Authors:  Erika W Lamb; Colleen D Walls; John T Pesce; Diana K Riner; Sean K Maynard; Emily T Crow; Thomas A Wynn; Brian C Schaefer; Stephen J Davies
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

Review 6.  A benefit-risk assessment of basiliximab in renal transplantation.

Authors:  Ugo Boggi; Romano Danesi; Fabio Vistoli; Marco Del Chiaro; Stefano Signori; Piero Marchetti; Mario Del Tacca; Franco Mosca
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

7.  The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells.

Authors:  Thomas Y Wuest; Jami Willette-Brown; Scott K Durum; Arthur A Hurwitz
Journal:  J Leukoc Biol       Date:  2008-07-23       Impact factor: 4.962

8.  DOCK8 regulates fitness and function of regulatory T cells through modulation of IL-2 signaling.

Authors:  Akhilesh K Singh; Ahmet Eken; David Hagin; Khushbu Komal; Gauri Bhise; Azima Shaji; Tanvi Arkatkar; Shaun W Jackson; Estelle Bettelli; Troy R Torgerson; Mohamed Oukka
Journal:  JCI Insight       Date:  2017-10-05

9.  Soluble cytokine receptors (sIL-2Rα, sIL-2Rβ) induce subunit-specific behavioral responses and accumulate in the cerebral cortex and basal forebrain.

Authors:  Steven S Zalcman; Ankur Patel; Ruchika Mohla; Youhua Zhu; Allan Siegel
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

10.  Time-Dependent Regulation of IL-2R α-Chain (CD25) Expression by TCR Signal Strength and IL-2-Induced STAT5 Signaling in Activated Human Blood T Lymphocytes.

Authors:  Alla N Shatrova; Elena V Mityushova; Irina O Vassilieva; Nikolay D Aksenov; Valery V Zenin; Nikolay N Nikolsky; Irina I Marakhova
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.